The role of ArlRS in regulating oxacillin susceptibility in methicillin-resistant Staphylococcus aureus indicates it is a potential target for antimicrobial resistance breakers

Emerg Microbes Infect. 2019;8(1):503-515. doi: 10.1080/22221751.2019.1595984.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA), also known as oxacillin-resistant S. aureus, is a leading cause of community and hospital associated infections globally. In this work, we found that deletion of the arlRS two-component system genes in the USA300 and USA500 strains resulted in increased susceptibilities to oxacillin (8-16-fold decrease in minimal inhibitory concentrations). In USA300ΔarlRS, transcriptional levels of mecA or blaZ showed no obvious change, while mRNA levels of spx showed a 4-fold decrease at 4 h and a 6.3-fold decrease at 10 h. Overexpression of spx in ΔarlRS restored oxacillin resistance to a similar level in USA300. In addition, gel shift assay showed that the recombinant ArlR bound to spx promoter region. Furthermore, silencing of spx led to a significant increase of oxacillin susceptibility in multiple MRSA isolates. Our results indicate that ArlRS plays a strong role in regulating oxacillin resistance in MRSA strains, which involves direct modulation of spx expression. Moreover, oritavancin showed inhibition to ATPase activity of the recombinant histidine kinase ArlS (IC50 = 5.47 μM). Oritavancin had synergy effect on oxacillin activity against the MRSA strains in both planktonic and biofilm state. Our data suggest that ArlRS is an attractive target for breaking antimicrobial resistance of MRSA.

Keywords: ArlRS; oxacillin; two-component signal transduction system.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • DNA, Bacterial / metabolism
  • Electrophoretic Mobility Shift Assay
  • Gene Deletion
  • Gene Expression Profiling
  • Gene Expression Regulation, Bacterial
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Oxacillin / pharmacology*
  • Promoter Regions, Genetic
  • Protein Binding
  • Protein Kinases / genetics
  • Protein Kinases / metabolism*
  • beta-Lactam Resistance*

Substances

  • Anti-Bacterial Agents
  • ArlR protein, Staphylococcus aureus
  • Bacterial Proteins
  • DNA, Bacterial
  • Protein Kinases
  • ArlS protein, Staphylococcus aureus
  • Oxacillin

Grants and funding

This work was supported by the National Natural Science Foundation of China [grant number 81671982, 81300810], Zhejiang Provincial Natural Science Foundation of China [grant number LY16H190006] and Zhengyi Scholar Program of Fudan University.